62 related articles for article (PubMed ID: 24535649)
1. Temporal analysis of intratumoral metabolic heterogeneity characterized by textural features in cervical cancer.
Yang F; Thomas MA; Dehdashti F; Grigsby PW
Eur J Nucl Med Mol Imaging; 2013 May; 40(5):716-27. PubMed ID: 23340594
[TBL] [Abstract][Full Text] [Related]
2. Deep learning-based combination of [18F]-FDG PET and CT images for producing pulmonary perfusion image.
Gu J; Qiu Q; Zhu J; Cao Q; Hou Z; Li B; Shu H
Med Phys; 2023 Dec; 50(12):7779-7790. PubMed ID: 37387645
[TBL] [Abstract][Full Text] [Related]
3. Low-order non-spatial effects dominate second-order spatial effects in the texture quantifier analysis of 18F-FDG-PET images.
Brooks FJ; Grigsby PW
PLoS One; 2015; 10(2):e0116574. PubMed ID: 25714472
[TBL] [Abstract][Full Text] [Related]
4. Reproducibility of tumor blood flow quantification with 15O-water PET.
Lodge MA; Jacene HA; Pili R; Wahl RL
J Nucl Med; 2008 Oct; 49(10):1620-7. PubMed ID: 18832120
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of multiple injection dynamic PET scans: an investigation of the benefits of pooling data from separate scans when mapping kinetics.
Gu F; O'Sullivan F; Muzi M; Mankoff DA
Phys Med Biol; 2021 Jul; 66(13):. PubMed ID: 34049293
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Perfusion Imaging with Total-Body PET.
Knuuti J; Tuisku J; Kärpijoki H; Iida H; Maaniitty T; Latva-Rasku A; Oikonen V; Nesterov SV; Teuho J; Jaakkola MK; Klén R; Louhi H; Saunavaara V; Nuutila P; Saraste A; Rinne J; Nummenmaa L
J Nucl Med; 2023 Nov; 64(Suppl 2):11S-19S. PubMed ID: 37918848
[TBL] [Abstract][Full Text] [Related]
7. Preliminary clinical assessment of the relationship between tumor alphavbeta3 integrin and perfusion in patients studied with [(18)F]fluciclatide kinetics and [ (15)O]H 2O PET.
Kenny LM; Tomasi G; Turkheimer F; Larkin J; Gore M; Brock CS; Mangar S; Aboagye EO
EJNMMI Res; 2014 Dec; 4(1):30. PubMed ID: 26055935
[TBL] [Abstract][Full Text] [Related]
8. In vivo imaging of glucose uptake and metabolism in tumors.
Walker-Samuel S; Ramasawmy R; Torrealdea F; Rega M; Rajkumar V; Johnson SP; Richardson S; Gonçalves M; Parkes HG; Arstad E; Thomas DL; Pedley RB; Lythgoe MF; Golay X
Nat Med; 2013 Aug; 19(8):1067-72. PubMed ID: 23832090
[TBL] [Abstract][Full Text] [Related]
9. Cardiac
Lee BC
J Nucl Cardiol; 2022 Jun; 29(3):1129-1131. PubMed ID: 33751477
[No Abstract] [Full Text] [Related]
10. Extracardiac findings with increased perfusion during clinical O-15-H
Jochumsen MR; Overgaard DL; Vendelbo MH; Madsen MA; Tolbod LP; Gormsen LC; Barkholt TØ
J Nucl Cardiol; 2023 Aug; 30(4):1458-1468. PubMed ID: 36600173
[TBL] [Abstract][Full Text] [Related]
11. Clinical translation of hyperpolarized
Qin H; Tang S; Riselli AM; Bok RA; Delos Santos R; van Criekinge M; Gordon JW; Aggarwal R; Chen R; Goddard G; Zhang CT; Chen A; Reed G; Ruscitto DM; Slater J; Sriram R; Larson PEZ; Vigneron DB; Kurhanewicz J
Magn Reson Med; 2022 Jan; 87(1):138-149. PubMed ID: 34374471
[TBL] [Abstract][Full Text] [Related]
12. Potential synergy between PSMA uptake and tumour blood flow for prediction of human prostate cancer aggressiveness.
Jochumsen MR; Sörensen J; Tolbod LP; Pedersen BG; Frøkiær J; Borre M; Bouchelouche K
EJNMMI Res; 2021 Feb; 11(1):12. PubMed ID: 33559792
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive quantification of tumor blood flow in prostate cancer using
Tolbod LP; Nielsen MM; Pedersen BG; Høyer S; Harms HJ; Borre M; Borghammer P; Bouchelouche K; Frøkiær J; Sørensen J
Am J Nucl Med Mol Imaging; 2018; 8(5):292-302. PubMed ID: 30510847
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia in cervical cancer: from biology to imaging.
Lyng H; Malinen E
Clin Transl Imaging; 2017; 5(4):373-388. PubMed ID: 28804704
[TBL] [Abstract][Full Text] [Related]
15. Targeting tumor microenvironment: crossing tumor interstitial fluid by multifunctional nanomedicines.
Omidi Y; Barar J
Bioimpacts; 2014; 4(2):55-67. PubMed ID: 25035848
[TBL] [Abstract][Full Text] [Related]
16. Combined measurement of tumor perfusion and glucose metabolism for improved tumor characterization in advanced cervical carcinoma. A PET/CT pilot study using [15O]water and [18F]fluorodeoxyglucose.
Apostolova I; Hofheinz F; Buchert R; Steffen IG; Michel R; Rosner C; Prasad V; Köhler C; Derlin T; Brenner W; Marnitz S
Strahlenther Onkol; 2014 Jun; 190(6):575-81. PubMed ID: 24535649
[TBL] [Abstract][Full Text] [Related]
17. Pilot study of combined FDG-PET and dynamic contrast-enhanced CT of locally advanced cervical carcinoma before and during concurrent chemoradiotherapy suggests association between changes in tumor blood volume and treatment response.
Banks TI; von Eyben R; Hristov D; Kidd EA
Cancer Med; 2018 Aug; 7(8):3642-3651. PubMed ID: 29963760
[TBL] [Abstract][Full Text] [Related]
18. Multiparametric [18F]Fluorodeoxyglucose/ [18F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study.
Pinker K; Andrzejewski P; Baltzer P; Polanec SH; Sturdza A; Georg D; Helbich TH; Karanikas G; Grimm C; Polterauer S; Poetter R; Wadsak W; Mitterhauser M; Georg P
PLoS One; 2016; 11(5):e0155333. PubMed ID: 27167829
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
